AGRX - Agile Therapeutics +13% on Twirla approval February, 14 2020 07:03 PM Agile Therapeutics Inc. Agile Therapeutics (NASDAQ:AGRX) is up 13% postmarket and on the move after announcing the FDA approved its Twirla contraceptive patch - its first approved product.More news on: Agile Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...